Efficacy and Long-term Safety of Telbivudine Usage During Second or Third Trimester in Hepatitis B Surface Antigen Positive Mothers With High Viral Load: A 10-year Prospective Study.

Hongxiu Jiang,Xiajun Ye,Chao Chen,Guanlun Zhou,Guorong Han

Journal of Clinical Gastroenterology（2023）

引用 0|浏览7

暂无评分

摘要

Treatment initiated during the second trimester could strengthen the success of mother-to-child transmission blockage. LdT treatment during pregnancy is safe for both mothers and infants in the long term.

查看译文

关键词

HBV infection,pregnancy,telbivudine,follow-up

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要